News

The rapid fire test, which was conducted at Medicago’s facility in Durham, North Carolina, is the fifth milestone under a technology investment agreement with DARPA to demonstrate the

Coldstream is also improving lyophilization capacity to expand the range of solvents that can safely be handled. The company expects to complete the upgrades in August 2012. Coldstream

Under the agreement with Chimerix, Merck will be responsible for development and commercialization of CMX157, an investigational oral nucleoside reverse transcriptase inhibitor currently in Phase I clinical development.

The companies will leverage and build upon EnviroLogix isothermal DNAblev2.0 chemistry and Douglas Scientific’s disruptive Array Tape Platform. Douglas Scientific president and COO Dan Malmstrom said the substantial

The multi-year program will study the impact of MTM intervention in the community pharmacy setting, with Walgreens expected to fund approximately $1m in in-kind services. HHS Secretary Kathleen

The patent provides the Schisandra Lignin extraction method and Schisandra-based products with market exclusivity for a period of 18 years. Renhuang Pharmaceuticals chairman and CEO Shaoming Li said

Immunomedics’ proprietary Dock-and-Lock (DNL) technology has been used to create the new anti-HIV agents. Immunomedics’ president and CEO Cynthia Sullivan said they are delighted with the collaboration with

The certification was based on the MedicsDocAssistant’s interoperability and interconnectivity with DHIN’s various data senders. DHIN’s various data sender healthcare companies include BayHealth Medical Center, Beebe Medical Center,

As part of the agreement, Myriad RBM will provide Bio-Rad with distribution rights for research purposes, to the catalog of quantitative multiplexed immunoassays present to run on the